At a glance
ClinicalIndex Comparison RecordN/ANot Yet Recruiting· 2,527 target
Drug / intervention
multi-cancer early detectiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility of Blood-based Test for Multi-cancer Early Detection in Asymptomatic Screening Population（ProSight）: a Multi-centre Interventional Study
In Brief
A clinical study evaluating multi-cancer early detection for Lung Cancer and 4 related conditions. Not yet recruiting, targeting 2,527 participants.
Detailed Summary
This is a prospective, multi-centre interventional study evaluating the feasibility of blood-based multi-cancer early detection test in asymptomatic screening cohort.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer, Colorectal Cancer, Liver Cancer, Grastic Cancer, Esophageal Cancer
Countries--
CollaboratorsFudan University
Timeline
N/ANot Yet Recruiting
202520262027
First PostedJan 2025
Enrollment StartMar 2025
TodayJul 2026
Primary CompletionDec 2026
First PostedJan 24, 2025
Enrollment StartMar 1, 2025
Primary CompletionDec 31, 2026
TodayJul 1, 2026
Enrollment to primary: 1.8 yearsPosted 1.4 years agoPrimary completion in 6 months
Interventions
multi-cancer early detectiondevice
Blood collection for multi-cancer early detection（MCED）, followed by clinical diagnosis based on the results of MCED and standard-of-care screening